- Home
- PAVM
PAVM
PAVmed Inc.
as 05-08-2025 4:00pm EST
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
Upcoming Earnings Alert:
Get ready for potential market movements as PAVmed Inc. PAVM prepares to release earnings report on 15 May 2025.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 12.0M | IPO Year: | 2016 |
| Target Price: | $19.50 | AVG Volume (30 days): | 74.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.50 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.55 - $2.42 | Next Earning Date: | 05-15-2025 |
| Revenue: | $2,995,000 | Revenue Growth: | 22.14% |
| Revenue Growth (this year): | -93.1% | Revenue Growth (next year): | 457.25% |
Latest PAVmed Inc. News
PAVM Breaking Stock News: Dive into PAVM Ticker-Specific Updates for Smart Investing
PR Newswire
8 days ago
PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025
PR Newswire
9 days ago
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025
Zacks
11 days ago
PAVmed (PAVM) Upgraded to Buy: Here's What You Should Know
PR Newswire
15 days ago
NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD
PR Newswire
a month ago
Lucid Diagnostics Announces Closing of Public Offering of Common Stock
PR Newswire
a month ago
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock
PR Newswire
a month ago
Lucid Diagnostics Announces Proposed Public Offering of Common Stock
PR Newswire
a month ago
Lucid Diagnostics to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference
Compare PAVM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PAVM PAVmed Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.